Corticosteroids in the management of acute exacerbations

Dennis E. Niewoehner, Kathryn Rice

Research output: Chapter in Book/Report/Conference proceedingChapter


Exacerbations of chronic obstructive pulmonary disease (COPD) have a major adverse impact on health status and place a serious burden on health care systems, particularly when they entail a visit to an emergency department or hospital admission (1). In 2000, COPD was responsible for 1.5 million emergency department visits and 726,000 hospitalizations in the United States (2). A hospital admission for COPD in the United States incurs average costs in excess of $16,000, so that hospitalization accounts for a large proportion of the total medical costs of caring for this disease (3,4). Because severe exacerbations are common, treatments that shorten their duration to even a small extent may provide substantial human and financial benefits in absolute terms.

Original languageEnglish (US)
Title of host publicationChronic Obstructive Pulmonary Disease Exacerbations
PublisherCRC Press
Number of pages10
ISBN (Electronic)9781420070873
ISBN (Print)142007086X, 9781420070866
StatePublished - Jan 1 2008


Dive into the research topics of 'Corticosteroids in the management of acute exacerbations'. Together they form a unique fingerprint.

Cite this